Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abvc Biopharma Inc (NQ: ABVC )

0.7599 -0.0011 (-0.14%)
Streaming Delayed Price Updated: 3:59 PM EST, Jan 27, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 41,024
Open 0.7700
Bid (Size) 0.7530 (28)
Ask (Size) 0.7800 (5)
Prev. Close 0.7610
Today's Range 0.7520 - 0.7800
52wk Range 0.5000 - 3.130
Shares Outstanding 24,470,526
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
ABVC BioPharma ABV-1505 ADHD Phase IIa Results Presented at 2023 APSARD Conference
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 133% to $0.3218. Swvl recently announced the commencement of a strategic review process. 
Via Benzinga

Performance

YTD
+26.65%
+26.65%
1 Month
+19.67%
+19.67%
3 Month
+4.10%
+4.10%
6 Month
+13.76%
+13.76%
1 Year
-69.23%
-69.23%

More News

Read More
What's happening With ABVC BioPharma Shares?
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Graphite Bio Shares Are Trading Lower By 50%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
Dow Falls Over 200 Points; Walgreens Earnings Top Expectations
Via Benzinga
Why ABVC BioPharma Shares Are Trading Higher By 129%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Nasdaq Down Over 100 Points; Crude Oil Rises 1%
Via Benzinga
FDA Approves IND Submission Allowing ABVC BioPharma to Proceed With Clinical Study of ABV-1519 for Treatment of Non-Small Cell Lung Cancer
Via NewMediaWire
Exposures Product Safety
SEC Goes After 'MrZackMorris, 'Stock Sniper' For Alleged Fraud
Via Benzinga
ABVC BioPharma Provides Vitargus Update - Phase II Vitargus Study Protocol Received Thai FDA Approval
Via NewMediaWire
Exposures Product Safety
Benzinga's Top Ratings Upgrades, Downgrades For November 16, 2022
Via Benzinga
ABVC BioPharma Reports Third Quarter 2022 Financial and Operational Results
Via NewMediaWire
ABVC BioPharma Receives Notice of Allowance from US Patent and Trademark Office for ABV-1504 Used to Treat Major Depressive Disorder (MDD)
Via NewMediaWire
Topics Intellectual Property
Exposures Intellectual Property
Cedars-Sinai Medical Center Joins Phase I Clinical Study of ABVC BioPharma's Medication for Treating Depression in Cancer Patients
Via NewMediaWire
ABVC BioPharma Announces Vitargus Phase II Study Plan Approved by HREC in Australia
Via NewMediaWire
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
ABVC BioPharma Provides ADHD Phase II Part 2 Clinical Study Update and Announces UCSF Institutional Review Board Approval
Via NewMediaWire
Why NanoVibronix Shares Surged Over 25%; Here Are 82 Biggest Movers From Friday
Via Benzinga
ABVC Biopharma Announces Letter to Shareholders
Via NewMediaWire
ABVC BioPharma Selects Additional Vitargus Phase II Study Site
Via NewMediaWire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Why Nikola Dropped Over 9%; Here Are 66 Biggest Movers From Yesterday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.